X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Add-On Hormone Therapy Regimens Boost Survival in Advanced Prostate Cancer

Androgen deprivation therapy (ADT) can slow the growth of aggressive prostate cancer and prolong survival in men with metastatic castration-sensitive disease (prostate cancer that has spread but responds to ADT). Two studies published in 2019 in The New England Journal of Medicine show that adding a second-generation androgen-receptor blocking drug can further improve survival in such men.

Read the full article here.

source: U C Berkeley